Skip to main content
IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
0.811
+0.061 (8.09%)
Mar 9, 2026, 1:44 PM EDT - Market open

IM Cannabis Revenue

IM Cannabis had revenue of 13.85M CAD in the quarter ending September 30, 2025, a decrease of -0.23%. This brings the company's revenue in the last twelve months to 52.38M, up 1.92% year-over-year. In the year 2024, IM Cannabis had annual revenue of 54.03M with 10.71% growth.

Revenue (ttm)
52.38M CAD
Revenue Growth
+1.92%
P/S Ratio
0.11
Revenue / Employee
551,389 CAD
Employees
95
Market Cap
4.25M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202454.03M5.23M10.71%
Dec 31, 202348.80M-5.53M-10.18%
Dec 31, 202254.34M20.28M59.56%
Dec 31, 202134.05M18.16M114.30%
Dec 31, 202015.89M6.82M75.12%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sunshine Biopharma 37.32M
cbdMD 19.09M
Sonoma Pharmaceuticals 17.72M
RedHill Biopharma 9.55M
InMed Pharmaceuticals 4.51M
China Pharma Holdings 4.05M
China SXT Pharmaceuticals 1.54M
Akanda 836.66K
Revenue Rankings

IMCC News

More News